Sinomed
Manufacturing · Netherlands · 501-1,000 Employees
View Company Info for Free
Overview
Headquarters
Wilhelminakade 173, Rotterdam, South Hol...Phone Number
+31 103076295Website
www.sinomed.comRevenue
$45.5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
2
2
1
1
1
1
About Sinomed
SINOMED is a global company focused on patient-centered medical innovations for interventional medicine, offering pioneering solutions for coronary, neurovascular, and structural heart diseases. Their product lineup includes the HT SUPREME® drug-coated coronary stent, the NOVA DES for neuro-interventional treatment, and the ACCUFIT transapical mitral valve replacement system. Founded in 2007, SINOMED has grown to become a leader in the Chinese coronary stent market and is publicly traded on the Shanghai STAR market. The company is committed to advancing healthcare innovation and invests significantly in clinical trials to ensure the safety and efficacy of its devices.Explore more
Sinomed Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Sinomed your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Sinomed, which may be a good buyer, showed buying intent in Masked Content Topic
Check out if Sinomed is spiking on competitors!
Product Launch: Get notified when Sinomed launches new products
Website visits: Recent activity has been detected on your website
Congratulate Masked Content for being promoted to Masked Content at Sinomed
Check if Sinomed has recently received funding, and reach out quickly before it becomes old news!
Click to see if Sinomed had a recent Job posting/layoffs
Earning: See what the market has to say on Sinomed recently announced quarterly report
Funding: Get notified immidiatlly once Sinomed has new funding data
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 2 more new buyers
Company Profile Activity
Activity Insights
Sinomed is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Sinomed is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Sinomed.
Sinomed Tech Stack
A closer look at the technologies used by Sinomed
Sinomed News & Media
SINOMED announces the first commercial implantation and European launch of the HT Supreme Drug Eluting Stent
TIANJIN, China, Aug. 17, 2021 /PRNewswire/ -- SINOMED, a leading international medical device company, announced the first commercial implantation of the HT Supreme® Drug-Eluting Stent (DES) at University Hospital Galway in partnership with the National University of Ireland Galway (NUI...SINOMED announces a clinical collaboration with the National University of Ireland Galway to evaluate a non-invasive assessment method for stenting
TIANJIN, China, July 5, 2021 /PRNewswire/ -- SINOMED, a leading international medical device company, today announced that they have teamed up with the National University of Ireland Galway (NUI Galway) to conduct a clinical trial for a new assessment method for stenting. The trial will...SINOMED announces the HT Supreme DES has similar performance as the market-leader across the spectrum of lesion complexity
TIANJIN, China, May 27, 2021 /PRNewswire/ -- SINOMED, a leading international medical device company, today announced results from the HT Supreme™ Healing-Targeted Drug-Eluting Stent (DES), in complex patients compared to the Xience or Promus family of DES. One-year results were presented...Late-Breaking Study Results of the Supreme HT™ Healing-Targeted DES Demonstrated Equivalent Outcomes with Exceptional Safety
TIANJIN, China, Nov. 17, 2020 /PRNewswire/ -- SINOMED® today announced that Prof. Alexandra Lansky from the Yale School of Medicine, USA, presented data from its first inter-continental PIONEER III study comparing the safety and efficacy of the Supreme HT (Healing-Targeted) Drug-Eluting...
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Sinomed
Sign Up For FreeTo access detailed company insights
SINOMED is a global company focused on patient-centered medical innovations for interventional medicine, offering pioneering solutions for coronary, neurovascular, and structural heart diseases. Their product lineup includes the HT SUPREME® drug-coated coronary stent, the NOVA DES for neuro-interventional treatment, and the ACCUFIT transapical mitr... Read More
